Media
Home
Media
- Press
Minoryx’s preclinical data for leriglitazone in Friedreich’s Ataxia published in Neurobiology of Disease JournalPreclinical data highlights potential therapeutic action and protection against neurodegeneration ...16/11/2020
European Investment Bank provides Minoryx with up to €25 million to support development of breakthrough therapies in orphan neurodegenerative diseasesEIB support to develop breakthrough treatments to address orphan neurodegenerative ...30/10/2020
Minoryx Therapeutics and Sperogenix Therapeutics enter into an exclusive license agreement to develop and commercialize leriglitazone in mainland China, Hong Kong and MacauSperogenix will receive exclusive rights to develop and commercialize leriglitazone ...23/09/2020Read more
- Events
Events in 2021
Events in 2020Events in 201911 Nov 2019 - 13 Nov 2019World Orphan Drug CongressBARCELONA11 Nov 2019 - 13 Nov 2019BIO-Europe 2019HAMBURG
